Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD - Wikidata - wikimedia - TriplyDB

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

http://www.wikidata.org/entity/Q24805375

about

Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 Imaging radiation response in tumor and normal tissue.Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins 18F-Labeled Peptides: The Future Is Bright Advanced tracers in PET imaging of cardiovascular disease Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas Integrins in cancer: biological implications and therapeutic opportunities Radiation-induced tumor neoantigens: imaging and therapeutic implications.Preclinical molecular imaging of tumor angiogenesis.Anatomical and molecular imaging of skin cancer Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.Combination of an Integrin-Targeting NIR Tracer and an Ultrasensitive Spectroscopic Device for Intraoperative Detection of Head and Neck Tumor Margins and Metastatic Lymph Nodes.[(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes.High-throughput in vivo screening of targeted molecular imaging agents.Identification of pancreatic cancer-specific cell-surface markers for development of targeting ligands Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation.Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs.Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging.Comparison of 99mTc-3PRGD2 integrin receptor imaging with 99mTc-MDP bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study.PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides.One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging

P2860

Q26767172-BCD69087-EE1D-4DC6-BA3A-61238A400D6C Q26771417-0931391F-AB49-4BB0-A0A4-C969C9200763 Q26798266-8C044C66-1690-4FCD-B083-024CE4BA3798 Q26801806-12AB0283-FF9E-463A-AE6C-3BD87EC42A46 Q27023393-091E7C88-F03D-45A8-A74D-7C22445CCC23 Q27023690-D806380E-DC70-4E19-80E7-50AD378001E8 Q27025187-8DFC5882-3A4E-46D2-A8DE-A352BC1BB292 Q28072021-ADEBF53E-7565-4FF9-91FA-1EBF4A4216D6 Q28550308-D0B63905-6BBA-4800-ADE6-303895A4FA9F Q29614536-FB00C7F1-7C9A-43D5-AC18-DD8EE53D7AAA Q30473856-B04AB10C-5BC8-46A8-8445-78E33372AD1A Q30475818-1FB90B33-8F0D-45A3-A615-2580106B325A Q30476227-40EAE40A-C915-4AA5-98E3-1023965541A3 Q30479243-CA52AD4C-250A-45CD-BB75-93F742B0814B Q30497615-CB52144B-50D0-41AF-ACCB-7043AC5F9AE5 Q30820507-B8B4263C-A397-4C86-B881-3B939E52822B Q31095114-ADB6EC46-0916-4930-A08A-3348B33AB1DB Q33358260-952B6B29-1873-4563-AB07-7E9AEFE6E2E1 Q33509447-ED88B7E5-554B-4C69-A3E5-425CC8896888 Q33567183-3D54936D-B613-4B73-ADC4-B3772F1EE0DE Q33574585-0B60EB8D-C109-46B8-ACD3-748674ABEBFA Q33578187-56D1B9AE-1D73-41F7-8F63-EE873902C7BC Q33637137-D4CF2538-9E6E-4433-B43B-9B20F6B653B6 Q33668360-CFFB59AE-F42F-4DCE-9C2B-9E023B32E77B Q33687901-F61ED5C8-8A01-4D4D-B863-F021F182A58B Q33696408-7A63E4C5-4755-42C5-8F91-A249BAC8CB57 Q33708506-59943DC9-D981-4437-93BA-37E6DE0E85E2 Q33767056-2D1CBAB7-573C-421B-B9E3-8A026AEBB15B Q33925952-74819169-DF4F-48E1-94E3-6971F7EAFA83 Q34039390-717CADA9-CB02-463F-AC90-CD4E4126798E Q34134316-AC8D754F-2367-4A24-98C3-24C665DD191F Q34134418-DB1CF1D1-04E8-4BBC-B786-2B7379D473F7 Q34159304-9B329BEF-7701-403F-8B16-50AF5A564DFB Q34159603-D7C3BBE8-6A87-495F-8A1B-DD28EFBD9E11 Q34167014-25CDF057-7400-4623-B675-2E3BE78A63FA Q34205400-5FD5836F-8F21-4EA8-AE5A-876B286CDEE8 Q34341677-66FB1339-F260-4103-B63F-F96EA0CBA456 Q34388500-1D000E9F-6F86-405D-9852-BE20948867EB Q34420335-E607BC15-E97B-4F4E-9722-F3586B5C0301 Q34435482-F6EFA15F-549A-4D7F-8C2A-CFDBD470F5F5

P2860

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

http://www.wikidata.org/entity/Q24805375

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@ast

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@en

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@nl

type

label

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@ast

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@en

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@nl

prefLabel

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@ast

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@en

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@nl

P1433

Q24805375-3DAE005E-6AB5-4B3D-84B2-1B516C1229CA

P1476

Q24805375-67ECB8CD-BA91-4667-B327-D63DBBC32DDA

P2093

Q24805375-2DA1DEB8-F4BF-494F-B4E6-8525D9BF7EEE

Q24805375-35230E4E-A414-4261-BBDF-B50D6E15DAB6

Q24805375-3E656145-9F2B-4633-8243-15E6B4F3785F

Q24805375-8B84749A-62C5-4D78-946D-D7C76E6B52B8

Q24805375-A3A13503-5346-42B5-B591-33E1CD67C984

Q24805375-D3B86D6C-4AFD-46F8-BB94-C3FC90CA9D57

Q24805375-DD0A6402-C5C9-4376-99CA-7EE6263C1327

Q24805375-E92DE4C0-70F0-4A11-A176-B3369AB464EC

Q24805375-E9E38855-AA13-41F1-9524-C2E03267CDD4

Q24805375-FF240417-A2F5-4929-86B1-461B51FF9992

P2860

Q24805375-00BB87BF-18D0-4D6E-91F4-8C077230E9DD

Q24805375-048742C3-A0FD-43BC-A766-67E1FA4135CE

Q24805375-0558DF3B-E037-42E4-B763-355998519DD8

Q24805375-095A19C0-1A1F-4D3E-BCEF-153A98EE5BDB

Q24805375-0F3B20D6-C59E-4718-9D82-1C8AA13B17CD

Q24805375-1619FA55-DF15-4590-A1B5-D4AC970CE493

Q24805375-1D8A5789-1565-4B2D-9962-9077F8A0AA2C

Q24805375-1F1EDA95-5C27-4A5F-86F6-1798EE3E4AC0

Q24805375-247A82AD-BDBB-47BE-B85C-106DB1B20605

Q24805375-2680EF58-8FD8-420A-BBFE-13E779E18839

P304

Q24805375-91BDA09D-8D55-41B1-9C1B-42A1DEA81B5C

P31

Q24805375-E9DA02A6-2886-4656-B588-90BB473C0D39

P3181

Q24805375-4E776D72-5950-490B-B81B-2F47EE756589

P356

Q24805375-FC6C2B1C-21B6-413C-9D69-8184BFDE725E

P407

Q24805375-08AFFBB9-AE36-453B-9667-3A906ECD931C

P433

Q24805375-E78C3E18-DBA5-4D34-88F7-8F0856FFBA17

P478

Q24805375-CE5F6AE3-E7A0-4F71-B79D-CC2D854E8AC8

P50

Q24805375-52685892-96BB-40E1-86FA-C6F0FABF69A6

Q24805375-FD17FCDC-3006-4E22-B244-15638E2E008F

P577

Q24805375-2189A0E3-C065-4770-A3BB-21E3639D9BC4

P5875

Q24805375-E9930610-D8EF-41B3-BE9D-03B0E336AF07

P698

Q24805375-A412BA98-F1CA-4E03-BF4D-CA22F12AB03B

P921

Q24805375-06BC7A94-941D-4555-8AB5-BEE3424AF28D

Q24805375-BBCABD0A-3670-4930-BC7E-C7870521E508

P932

Q24805375-23854C94-EF3A-49A7-9EAC-CFB205A0D76F

P3181

P356

JOURNAL.PMED.0020070

P1433

P1476

Noninvasive visualization of t ...... omography and [18F]Galacto-RGD

@en

P2093

Ambros J Beer

http://www.w3.org/2001/XMLSchema#string

Daniel Reim

http://www.w3.org/2001/XMLSchema#string

Eugenija Vabuliene

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Horst Kessler

http://www.w3.org/2001/XMLSchema#string

Mario Sarbia

http://www.w3.org/2001/XMLSchema#string

Michael Goebel

http://www.w3.org/2001/XMLSchema#string

Roland Haubner

http://www.w3.org/2001/XMLSchema#string

Rüdiger Hein

http://www.w3.org/2001/XMLSchema#string

Wolfgang A Weber

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Requirement of vascular integrin alpha v beta 3 for angiogenesis

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.

Specialization of tumour vasculature.

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

The alpha v beta 3 integrin as a tumor homing ligand for lymphocytes.

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.

P304

e70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

434311

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0020070

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Karl-Friedrich Becker

Markus Schwaiger

P577

2005-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7952395

http://www.w3.org/2001/XMLSchema#string

P698

15783258

http://www.w3.org/2001/XMLSchema#string

P921

P932

1069665

http://www.w3.org/2001/XMLSchema#string